Lapatinib in Treating Brain Metastases in Patients With Stage IV Breast Cancer and Brain Metastases
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Central Nervous System Metastases|HER2-positive Breast Cancer|Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer|Tumors Metastatic to Brain
Interventions: DRUG: lapatinib ditosylate|OTHER: laboratory biomarker analysis|PROCEDURE: quality-of-life assessment|OTHER: questionnaire administration
Sponsor: National Cancer Institute (NCI)